Parietal cell vagotomy.
Although long-term follow-up data have not been obtained, it appears that parietal cell vagotomy for the treatment of intractable duodenal ulcer is withstanding the test of time. Operative mortality and morbidity are low, as is the incidence of side effects. The majority of patients who have a recurrent ulcer improve with medical therapy, and only a minority require reoperation.
D004106:Dilatation; D004381:Duodenal Ulcer / Q000503:physiopathology / Q000601:surgery*; D005753:Gastric Mucosa / Q000378:metabolism; D006801:Humans; D011183:Postoperative Complications; D011707:Pyloric Stenosis / Q000150:complications / Q000628:therapy; D012008:Recurrence; D013270:Stomach / Q000294:innervation; D014628:Vagotomy / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D014630:Vagus Nerve / Q000033:anatomy & histology